Hanoi Medical University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Hanoi Vietnam (1902)

Organization Overview

First Clinical Trial
2004
NCT00811239
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Center of Clinical Pharmacology, Hanoi Medical University | Centre of Clinical Pharmacology, Hanoi Medical University | Hanoi Medical University | Hanoi Medical University Hospital | Hanoi Medical University, Vietnam | National Hospital of Obstetrics and Gynecology

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 2)

Hypersensitivity (Phase 2)

Insulin Resistance (Phase 2)

Snake Bites (Phase 2)

Substance-Related Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial APIs: 15